Medical devices
Medical devices
Medical devices
Information session on the pilot for expert panels' advice for orphan medical devices, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024, 14:00 (CEST) to 23 September 2024, 16:00 (CEST)
European Shortages Monitoring Platform Essentials and Industry Reporting Requirements, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 June 2024, 10:00 (CEST) to 24 June 2024, 12:30 (CEST)
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 41, Status: Authorised
Policy 82: Union Product Database (UPD) Access Policy - Veterinary Medicinal Products
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 59, Status: Authorised
PRIME: priority medicines
List of medicines currently in PRIME scheme
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 22-25 July 2024